Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Research Evidence The body of BPC-157 research consists primarily of preclinical animal studies, with very limited human clinical data
Liu H, Ye M, Guo H
It was approved in 2010 for type 2 diabetes as Victoza, and in 2017 for weight loss as Saxenda
Out of the nine participants who responded to therapy, 8 reported improvement in the Parent Interview for Autism Clinical Version (PIA-CV)
US$ 25.21
US$ 27.16
US$ 24.74
US$ 27.78
US$ 26.09
